New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

In fact, a study published in the Journal of Royal Society of Medicine revealed that if lung cancer in non-smokers was classified as a separate disease, it would rank as the eighth most common cause ...

Stage 3 non-small cell lung cancer (NSCLC) is lung cancer that has spread to nearby (regional) tissues. Stage 3 also has three sub-stages that give more details about how and where the cancer has ...